Cryoport Supports Stemedica’s Ischemic-Tolerant Stem Cell Product Lines

LAKE FOREST, Calif., Aug. 18, 2015 /PRNewswire/ — Cryoport, Inc. (NASDAQ: CYRX) (“Cryoport” or the “Company”), the leading provider of advanced cryogenic logistics solutions for the life sciences industry, today announced that its validated cryogenic …

[Read the full article here]

Comments are closed.